Chile find AstraZeneca shots safe
Chilean investigators testing the AstraZeneca-Oxford University Covid-19 vaccination in 2,200 people found no instances of blood clots among participants, they said on Friday. Dr Maria Elena Santolaya, from the University of Chile which led the trial, said the study included people of all ages, with 20% of them over 60 years old. More than a dozen European countries suspended or restricted use of AstraZeneca's Covid-19 vaccine, called Vaxzevria, amid reports of blood clots combined with low platelets in a very small number of people who received it. Vaxzevria was approved for emergency use in Chile in January for men over 18 and women over 55 but will be used only for men since most women over 55 in Chile have already been vaccinated, the health minister said.
Comments